![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
1-Adrenoceptors: Effects on Receptor Expression and Pharmacological Properties
Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia
The potential role of dimerization in controlling the expression and pharmacological properties of 
1-adrenoceptor subtypes was examined using coimmunoprecipitation of epitope-tagged receptors. Human 1-adrenoceptor subtypes (1A, 1B, 1D) were tagged at their amino-termini with Flag or hemagglutinin epitopes and transfected into human embryonic kidney 293 cells. Homodimerization of all three subtypes was observed by coimmunoprecipitation of receptors with different tags and was not altered by norepinephrine treatment. Heterodimer formation between hemagglutinin-tagged 1B-adrenoceptors and Flag-tagged 1A- or 1D-adrenoceptors was also observed. However, no 1A/1D-adrenoceptor heterodimers were observed, suggesting that dimerization is subtype-specific. The extent of heterodimerization was also unaltered by norepinephrine treatment. 1-Adrenoceptor truncation mutants lacking carboxyl or amino-terminal sequences formed homo- and heterodimers similarly to full-length receptors, suggesting that these domains play little or no role in dimerization. Biotinylation with a membrane-impermeable agent showed that monomers and homo- and hetero-oligomers of all three subtypes are expressed on the cell surface. Radioligand binding studies showed that heterodimerization did not alter the affinity of 1-adrenoceptors for norepinephrine, prazosin, or subtype-selective antagonists, suggesting that dimerization does not result in pharmacologically distinct subtypes. However, coexpression of 1B-adrenoceptors significantly increased both binding site density and protein expression of 1A- and 1D-adrenoceptors, and increased cell surface expression of 1D-adrenoceptors, suggesting a functional role for heterodimerization. Conversely, coexpression of 1A-with 1D-adrenoceptors, which did not heterodimerize, had no effect on receptor density or protein. These studies demonstrate subtype-selective heterodimerization of 1-adrenoceptors, which does not change their pharmacological properties but seems to have functional consequences in regulating receptor expression and trafficking.
Received January 28, 2003; accepted August 29, 2003.
Address correspondence to: Kenneth P. Minneman, Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Atlanta GA 30322. E-mail: kminneman{at}pharm.emory.edu
This article has been cited by other articles:
|
|
 |
|
  J. S. Lyssand, M. C. DeFino, X.-b. Tang, A. L. Hertz, D. B. Feller, J. L. Wacker, M. E. Adams, and C. Hague Blood Pressure Is Regulated by an {alpha}1D-Adrenergic Receptor/Dystrophin Signalosome J. Biol. Chem., July 4, 2008; 283(27): 18792 - 18800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hosoda, M. Hiroyama, A. Sanbe, J.-i. Birumachi, T. Kitamura, S. Cotecchia, P. C. Simpson, G. Tsujimoto, and A. Tanoue Blockade of both {alpha}1A- and {alpha}1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H514 - H519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Bush, S. V. Jones, A. N. Lyle, K. P. Minneman, K. J. Ressler, and R. A. Hall Specificity of Olfactory Receptor Interactions with Other G Protein-coupled Receptors J. Biol. Chem., June 29, 2007; 282(26): 19042 - 19051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Prinster, T. G. Holmqvist, and R. A. Hall {alpha}2C-Adrenergic Receptors Exhibit Enhanced Surface Expression and Signaling upon Association with beta2-Adrenergic Receptors J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 974 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. C. Kong, T. Fan, G. Varghese, B. F. O'Dowd, and S. R. George Agonist-Induced Cell Surface Trafficking of an Intracellularly Sequestered D1 Dopamine Receptor Homo-Oligomer Mol. Pharmacol., July 1, 2006; 70(1): 78 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, C. Hague, R. A. Hall, and K. P. Minneman Syntrophins Regulate {alpha}1D-Adrenergic Receptors through a PDZ Domain-mediated Interaction J. Biol. Chem., May 5, 2006; 281(18): 12414 - 12420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Finch and R. M. Graham The {alpha}1D-Adrenergic Receptor: Cinderella or Ugly Stepsister Mol. Pharmacol., January 1, 2006; 69(1): 1 - 4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Prinster, C. Hague, and R. A. Hall Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Uberti, C. Hague, H. Oller, K. P. Minneman, and R. A. Hall Heterodimerization with {beta}2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of {alpha}1D-Adrenergic Receptors J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 16 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hosoda, T.-a. Koshimizu, A. Tanoue, Y. Nasa, R. Oikawa, T. Tomabechi, S. Fukuda, H. Shinoura, S. Oshikawa, S. Takeo, et al. Two {alpha}1-Adrenergic Receptor Subtypes Regulating the Vasopressor Response Have Differential Roles in Blood Pressure Regulation Mol. Pharmacol., March 1, 2005; 67(3): 912 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Carrillo, J. F. Lopez-Gimenez, and G. Milligan Multiple Interactions between Transmembrane Helices Generate the Oligomeric {alpha}1b-Adrenoceptor Mol. Pharmacol., November 1, 2004; 66(5): 1123 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hague, M. A. Uberti, Z. Chen, C. F. Bush, S. V. Jones, K. J. Ressler, R. A. Hall, and K. P. Minneman Olfactory receptor surface expression is driven by association with the {beta}2-adrenergic receptor PNAS, September 14, 2004; 101(37): 13672 - 13676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-a. Koshimizu, G. Tsujimoto, A. Hirasawa, Y. Kitagawa, and A. Tanoue Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human {alpha}1D- and {alpha}1B-adrenergic receptors Cardiovasc Res, September 1, 2004; 63(4): 662 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ramsay, I. C. Carr, J. Pediani, J. F. Lopez-Gimenez, R. Thurlow, M. Fidock, and G. Milligan High-Affinity Interactions between Human {alpha}1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the {alpha}1L-Adrenoceptor Mol. Pharmacol., August 1, 2004; 66(2): 228 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Milligan G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology Mol. Pharmacol., July 1, 2004; 66(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hague, M. A. Uberti, Z. Chen, R. A. Hall, and K. P. Minneman Cell Surface Expression of {alpha}1D-Adrenergic Receptors Is Controlled by Heterodimerization with {alpha}1B-Adrenergic Receptors J. Biol. Chem., April 9, 2004; 279(15): 15541 - 15549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Israilova, T. Tanaka, F. Suzuki, S. Morishima, and I. Muramatsu Pharmacological Characterization and Cross Talk of {alpha}1A- and {alpha}1B-Adrenoceptors Coexpressed in Human Embryonic Kidney 293 Cells J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 259 - 266. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
